FAP Expression in Renal Tumors Assessed by [68Ga]Ga-FAPI-46 PET Imaging and FAP Immunohistochemistry: A Case Series of Six Patients from the Prospective Exploratory Trial NCT04147494

By afschroeder • October 17, 2025

Holzgreve A, Unterrainer LM, Flores K, Lam EC, Mona CE, Czernin J, Shuch BM, Sisk AE Jr, Calais J. FAP Expression in Renal Tumors Assessed by [⁶⁸Ga]Ga-FAPI-46 PET Imaging and FAP Immunohistochemistry: A Case Series of Six Patients from the Prospective Exploratory Trial NCT04147494. J Nucl Med. 2025 Oct 16:jnumed.125.270346. doi: 10.2967/jnumed.125.270346. Epub ahead of print. PMID: 41101974.

Tags: Cardiology/Epi, fibroblast activation protein inhibitor, kidney, NCT04147494, oncocytoma, Publications, RCC, Renal cell carcinoma

Hypertension Prevalence and Control at Trial Entry in the REPRIEVE Study Population: Results From a Secondary Analysis

Hoffman R, Watanabe M, Martínez E, Zanni MV, Pozniak A, Shakil SS, McCallum S, Chu SM, Srinivasa S, Malvestutto CD, Fichtenbaum CJ, Bloomfield GS, Lu[...]

Lipids and lipoproteins in calcific aortic valve disease

Aksoy O, Tintut Y, Demer LL. Lipids and lipoproteins in calcific aortic valve disease. Curr Opin Lipidol. 2026 Oct 1;37(5):185-190. doi: 10.1097/MOL.0000000000001053. Epub 2026 Aug[...]

Lipids in endothelial-to-mesenchymal transition

Tripsas CK, Tsai AY, Hsu JJ. Lipids in endothelial-to-mesenchymal transition. Curr Opin Lipidol. 2026 Oct 1;37(5):177-184. doi: 10.1097/MOL.0000000000001051. Epub 2026 Aug 12. PMID: 42592967.